Journal Mobile Options
Table of Contents
Vol. 82, No. 1, 2013
Issue release date: November 2012
Psychother Psychosom 2013;82:45–52
(DOI:10.1159/000337746)

The Association between Physical Morbidity and Subtypes of Severe Depression

Østergaard S.D. · Petrides G. · Dinesen P.T. · Skadhede S. · Bech P. · Munk-Jørgensen P. · Nielsen J.
aUnit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital, Aalborg, bDepartment of Political Science, University of Copenhagen, Copenhagen, and cPsychiatric Research Unit, Psychiatric Center Nordsjælland, Copenhagen University Hospital, Hillerød, Denmark; dZucker Hillside Hospital, Northshore-LIJ Health System, Glen Oaks, N.Y., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Physical illness and depression are related, but the association between specific physical diseases and diagnostic subtypes of depression remains poorly understood. This study aimed to clarify the relationship between a number of physical diseases and the nonpsychotic and psychotic subtype of severe depression. Methods: This is a historical prospective cohort study. The study population consisted of all patients diagnosed with ICD-10 severe depression, either nonpsychotic or psychotic subtype, in Danish psychiatric hospitals between 1994 and 2008. The patients’ history of physical disease was assessed using the Danish National Patient Register. Using logistic regression it was investigated whether specific physical diseases were associated with relative increased risk for subsequent development of either the nonpsychotic or psychotic depressive subtype. Results: A total of 24,173 patients with severe depression were included in the study. Of those, 8,260 (34%) were of the psychotic subtype. A history of the following physical diseases, as opposed to their absence, increased the relative risk for subsequent development of the nonpsychotic compared to the psychotic depressive subtype [adjusted incidence odds ratio (AIOR) nonpsychotic vs. psychotic]: ischemic heart disease (AIOR = 1.3, p < 0.001), hypertension (AIOR = 1.2, p = 0.008), stroke (AIOR = 1.2, p = 0.042) and chronic lower pulmonary disease (AIOR = 1.2, p = 0.005). The total load of physical disease also increased the relative risk of nonpsychotic depression [AIOR = 1.05 (per disease), p = 0.001]. Conclusions: This study revealed that, in severe depression, a history of physical disease increased the relative risk of the nonpsychotic rather than the psychotic subtype.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Brown LH, Strauman T, Barrantes-Vidal N, Silvia PJ, Kwapil TR: An experience-sampling study of depressive symptoms and their social context. J Nerv Ment Dis 2011;199:403–409.

    External Resources

  2. Goldberg D: The detection and treatment of depression in the physically ill. World Psychiatry 2010;9:16–20.

    External Resources

  3. Ostergaard SD, Foldager L: The association between physical illness and major depressive episode in general practice. Acta Psychiatr Scand 2011;123:290–296.
  4. Huijbregts KM, van Marwijk HW, de Jong FJ, Schreuders B, Beekman AT, van der Feltz-Cornelis CM: Adverse effects of multiple physical symptoms on the course of depressive and anxiety symptoms in primary care. Psychother Psychosom 2010;79:389–391.
  5. van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW: Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010;122:30–39.
  6. Cumming TB, Churilov L, Skoog I, Blomstrand C, Linden T: Little evidence for different phenomenology in poststroke depression. Acta Psychiatr Scand 2010;121:424–430.
  7. Patten SB, Williams JV, Lavorato DH, Campbell NR, Eliasziw M, Campbell TS: Major depression as a risk factor for high blood pressure: epidemiologic evidence from a national longitudinal study. Psychosom Med 2009;71:273–279.

    External Resources

  8. Rieckmann N, Burg MM, Kronish IM, Chaplin WF, Schwartz JE, Davidson KW: Aspirin adherence, depression and one-year prognosis after acute coronary syndrome. Psychother Psychosom 2011;80:316–318.
  9. Poletti M, Frosini D, Pagni C, Lucetti C, Del Dotto P, Ceravolo R, Bonuccelli U: Alexithymia is associated with depression in de novo Parkinson’s disease. Psychother Psychosom 2011;80:251–253.
  10. Egan BM, Zhao Y, Axon RN: US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 2010;303:2043–2050.
  11. Lippi G, Montagnana M, Favaloro EJ, Franchini M: Mental depression and cardiovascular disease: a multifaceted, bidirectional association. Semin Thromb Hemost 2009;35:325–336.

    External Resources

  12. Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008;31:2383–2390.

    External Resources

  13. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS: Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997;13:116–137.
  14. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B: Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851–858.
  15. Harter M, Baumeister H, Reuter K, Jacobi F, Hofler M, Bengel J, Wittchen HU: Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom 2007;76:354–360.
  16. Dworkin SF, Von Korff M, LeResche L: Multiple pains and psychiatric disturbance. An epidemiologic investigation. Arch Gen Psychiatry 1990;47:239–244.
  17. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva, World Health Organization, 1992.
  18. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, Text Revision. Washington, American Psychiatric Association, 2000.
  19. Ostergaard SD, Rothschild AJ, Uggerby P, Munk-Jorgensen P, Bech P, Mors O: Considerations on the ICD-11 classification of psychotic depression. Psychother Psychosom. Accepted for publication.
  20. Schatzberg AF, Rothschild AJ: Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV? Am J Psychiatry 1992;149:733–745.
  21. Coryell W: The treatment of psychotic depression. J Clin Psychiatry 1998;59(suppl 1):22–29.

    External Resources

  22. Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, Rummans TA, O’Connor KM, Rasmussen KG Jr, Bernstein HJ, Biggs M, Bailine SH, Kellner CH: ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT 2001;17:244–253.
  23. Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L: Phenomenology and prognostic significance of delusions in major depressive disorder: a 10-year prospective follow-up study. J Clin Psychiatry 2007;68:1411–1417.

    External Resources

  24. Vythilingam M, Chen J, Bremner JD, Mazure CM, Maciejewski PK, Nelson JC: Psychotic depression and mortality. Am J Psychiatry 2003;160:574–576.
  25. Lichtenberg P, Belmaker RH: Subtyping major depressive disorder. Psychother Psychosom 2010;79:131–135.
  26. Bech P: Struggle for subtypes in primary and secondary depression and their mode-specific treatment or healing. Psychother Psychosom 2010;79:331–338.
  27. Leckman JF, Weissman MM, Prusoff BA, Caruso KA, Merikangas KR, Pauls DL, Kidd KK: Subtypes of depression. Family study perspective. Arch Gen Psychiatry 1984;41:833–838.
  28. Domschke K, Lawford B, Young R, Voisey J, Morris CP, Roehrs T, Hohoff C, Birosova E, Arolt V, Baune BT: Dysbindin (DTNBP1) – a role in psychotic depression? J Psychiatr Res 2011;45:588–595.

    External Resources

  29. Frank L: Epidemiology. When an entire country is a cohort. Science 2000;287:2398–2399.
  30. Mors O, Perto GP, Mortensen PB: The Danish Psychiatric Central Research Register. Scand J Public Health 2011;39:54–57.

    External Resources

  31. Munk-Jorgensen P, Ostergaard SD: Register-based studies of mental disorders. Scand J Public Health 2011;39:170–174.

    External Resources

  32. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH: The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;46:263–268.
  33. Gaist D, Sorensen HT, Hallas J: The Danish prescription registries. Dan Med Bull 1997;44:445–448.
  34. Statistics Denmark: IDA: An Integrated Database for Labour Market Research (in Danish). Copenhagen, Statistics Denmark Press, 1991.
  35. Danish National Board of Health: Classification of Diseases: Extended Danish-Latin Version of the World Health Organization International Statistical Classification of Diseases and Related Health Problems, 8th Revision. Copenhagen, Danish National Board of Health, 1971.
  36. Nickelsen TN: Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 2001;164:33–37.
  37. World Health Organization. www.whocc.no/atc; 2010.
  38. Gournellis R, Lykouras L: Psychotic (delusional) major depression in the elderly: a review. Curr Psychiatry Rev 2006:235–244.

    External Resources

  39. Coryell W, Pfohl B, Zimmerman M: The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 1984;172:521–528.
  40. Bock C, Bukh JD, Vinberg M, Gether U, Kessing LV: Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health 2009;5:4.

    External Resources

  41. Kivela SL, Pahkala K: Delusional depression in the elderly: a community study. Z Gerontol 1989;22:236–241.
  42. Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M: ‘Vascular depression’ hypothesis. Arch Gen Psychiatry 1997;54:915–922.
  43. Taylor WD, Steffens DC, Krishnan KR: Psychiatric disease in the twenty-first century: the case for subcortical ischemic depression. Biol Psychiatry 2006;60:1299–1303.

    External Resources

  44. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997;154:497–501.
  45. Putman-Casdorph H, McCrone S: Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009;38:34–47.

    External Resources

  46. Giltay EJ, Nissinen A, Giampaoli S, Zitman FG, Kromhout D: Low respiratory function increases the risk of depressive symptoms in later life in men. Psychosom Med 2010;72:53–60.

    External Resources

  47. Goodwin RD: Is COPD associated with suicide behavior? J Psychiatr Res 2011;45:1269–1271.

    External Resources

  48. Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Girtler N, Holmes C, Hurt C, Marriott A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH: Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium. Part 1. Dement Geriatr Cogn Disord 2007;24:457–463.
  49. Castilla-Puentes RC, Habeych ME: Subtypes of depression among patients with Alzheimer’s disease and other dementias. Alzheimers Dement 2010;6:63–69.

    External Resources

  50. Wijkstra J, Burger H, van den Broek WW, Birkenhager TK, Janzing JG, Boks MP, Bruijn JA, van der Loos ML, Breteler LM, Verkes RJ, Nolen WA: Long-term response to successful acute pharmacological treatment of psychotic depression. J Affect Disord 2010;123:238–242.

    External Resources

  51. Wijkstra J, Lijmer J, Balk F, Geddes J, Nolen WA: Pharmacological treatment for psychotic depression. Cochrane Database Syst Rev 2005;4:CD004044.
  52. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE: Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry 2010;167:509–527.
  53. Mann JJ, Currier DM: Stress, genetics and epigenetic effects on the neurobiology of suicidal behavior and depression. Eur Psychiatry 2010;25:268–271.
  54. Uher R, McGuffin P: The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update. Mol Psychiatry 2010;15:18–22.
  55. Karg K, Burmeister M, Shedden K, Sen S: The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry 2011;68:444–454.

    External Resources

  56. Fava GA, Guidi J, Semprini F, Tomba E, Sonino N: Clinical assessment of allostatic load and clinimetric criteria. Psychother Psychosom 2010;79:280–284.
  57. Fava GA, Sonino N, Wise TN: Principles of psychosomatic assessment. Adv Psychosom Med 2012;32:1–18.

    External Resources

  58. Fava GA, Sonino N: Psychosomatic assessment. Psychother Psychosom 2009;78:333–341.
  59. Baumeister H, Hutter N, Bengel J, Harter M: Quality of life in medically ill persons with comorbid mental disorders: a systematic review and meta-analysis. Psychother Psychosom 2011;80:275–286.
  60. Guidi J, Fava GA, Picardi A, Porcelli P, Bellomo A, Grandi S, Grassi L, Pasquini P, Quartesan R, Rafanelli C, Rigatelli M, Sonino N: Subtyping depression in the medically ill by cluster analysis. J Affect Disord 2011;132:383–388.
  61. Parker G: Major running on the spot. World Psychiatry 2010;9:165–166.

    External Resources

  62. Ostergaard SD, Jensen SO, Bech P: The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatr Scand 2011;124:495–496.
  63. Byrne N, Regan C, Howard L: Administrative registers in psychiatric research: a systematic review of validity studies. Acta Psychiatr Scand 2005;112:409–414.
  64. Rothschild AJ, Winer J, Flint AJ, Mulsant BH, Whyte EM, Heo M, Fratoni S, Gabriele M, Kasapinovic S, Meyers BS, Study of Pharmacotherapy of Psychotic Depression (STOP-PD) Collaborative Study Group: Missed diagnosis of psychotic depression at 4 academic medical centers. J Clin Psychiatry 2008;69:1293–1296.

    External Resources

  65. Seemuller F, Riedel M, Obermeier M, Schennach-Wolff R, Spellmann I, Meyer S, Bauer M, Adli M, Kronmuller K, Ising M, Brieger P, Laux G, Bender W, Heuser I, Zeiler J, Gaebel W, Moller HJ: The validity of self-rated psychotic symptoms in depressed inpatients. Eur Psychiatry 2011, E-pub ahead of print.
  66. Rothschild AJ: Clinical Manual for Diagnosis and Treatment of Psychotic Depression. Arlington, American Psychiatric Publishing, 2009.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50